First AD

Second AD

Acute and Preventive Treatment: Differences and QOL Impact

Acute Migraine Treatment: Prevalence and Classes of Agents

Acute Migraine Therapy Unmet Needs 

Drivers of Health Care Utilization for Uncontrolled Migraine

Advancements in Migraine Diagnosis and Treatment

Determining and Measuring Individualized Treatment Goals 

Transitioning from Acute to Preventive Care

Historical Perspective on Preventive Care

New CGRP Monoclonal Antibodies for Preventive Care

CGRP Monoclonal Antibodies: AEs and Efficacy 

Patient-Reported Outcomes Data on Adverse Events

Migraine Therapy Selection and Duration 

Measuring Response in Goal-Based Therapy 

Combining Acute and Preventive Therapy 

Managing Migraine Patients During the Pandemic

Peer Exchange

Migraine

Key opinion leaders discuss the differences between acute and preventive treatment in migraine, clinical guidelines and treatment selections, and options for migraine management and prevention.

Acute and Preventive Therapy for Migraine 